Aktiia, a Swiss HealthTech innovator, has garnered USD 30M to enhance its optical blood pressure monitoring solutions. Leading this investment round is Redalpine, joined by key players such as Khosla Ventures and Molten. The infusion of capital aims to propel Aktiia's advancements in managing hypertension, a pressing global health issue. Investors have recognized the potential impact of Aktiia's technology on public health.